Stockreport

Pear Therapeutics Announces Process Exploring Strategic Alternatives

Pear Therapeutics, Inc. - Class A  (PEAR) 
PDF BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. (Nasdaq: PEAR) (“the Company”), the leader in developing and commercializing software-based medicines called prescri [Read more]